SCHEMBL2058362

SCHEMBL2058362

C=C(C)/C=C/OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058364 1.00
SCHEMBL3695254 0.78 ALDH1A1 (0.39)
SCHEMBL36621 0.78 ALDH1A1 (0.39)
SCHEMBL8258470 0.75
SCHEMBL23501997 0.73
SCHEMBL9679825 0.73
SCHEMBL9679823 0.73
SCHEMBL9588262 0.73
SCHEMBL9219002 0.73
SCHEMBL10405205 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0806405-A1 Process for the preparation of hexahydrofarnesylacetone from 6,7-dihydrogeraniol and intermediates for their production BASF AKTIENGESELLSCHAFT (DE) 1997-11-12 EP claimed
US-20180111889-A1 METHODS OF MAKING MULTICYCLIC COMPOUNDS USING MULTICOMPONENT/TANDEM REACTION SEQUENCES BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2018-04-26 US disclosed
US-9944658-B2 Beta-lactamase inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2018-04-17 US disclosed
US-20180065966-A1 Antimicrobial Compounds And Methods Of Making And Using The Same MELINTA THERAPEUTICS, INC. 2018-03-08 US disclosed
US-9409879-B2 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-08-09 US disclosed
US-9327281-B2 Carbon-dioxide compound and catalyst MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-05-03 US disclosed
US-20160024121-A1 BETA-LACTAMASE INHIBITORS VenatoRx Pharmaceuticals, Inc. 2016-01-28 US disclosed
US-20150306590-A1 CARBON-DIOXIDE COMPOUND AND CATALYST MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-10-29 US disclosed
US-20140121238-A1 TOTAL SYNTHESIS OF REDOX-ACTIVE 1.4-NAPHTHOQUINONES AND THEIR METABOLITES AND THEIR THERAPEUTIC USE AS ANTIMALARIAL AND SCHISTOMICIDAL AGENTS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-05-01 US disclosed
US-8440706-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-14 US disclosed
US-7067703-B2 Manufacture of retinoids DSM IP ASSETS B.V. (NL) 2006-06-27 US disclosed
US-20050014976-A1 Manufacture of retinoids DSM IP ASSETS B.V. (NL) 2005-01-20 US disclosed
EP-1442014-A1 MANUFACTURE OF RETINOIDS DSM IP Assets B.V. (NL) 2004-08-04 EP disclosed
WO-2003037856-A1 MANUFACTURE OF RETINOIDS DSM IP ASSETS B.V. (NL) 2003-05-08 WO disclosed
US-5767325-A Preparation of enol ethers BASF AKTIENGESELLSCHAFT (DE) 1998-06-16 US disclosed
EP-0806405-A1 Process for the preparation of hexahydrofarnesylacetone from 6,7-dihydrogeraniol and intermediates for their production BASF AKTIENGESELLSCHAFT (DE) 1997-11-12 EP disclosed
EP-0776879-A1 Process for the preparation of enol ethers BASF AKTIENGESELLSCHAFT (DE) 1997-06-04 EP disclosed
US-4225514-A FROM A SUBSTITUTED PYRAN HOFFMANN-LA ROCHE INC. (US) 1980-09-30 US disclosed
US-4071538-A Pyran aldehydes HOFFMANN-LA ROCHE INC. (US) 1978-01-31 US disclosed
US-3997529-A 2-(CYCLOHEXENYLALKENYL)-6-ALKOXY-3,6-DIHYDO-2H-PYRANS HOFFMANN-LA ROCHE INC. (US) 1976-12-14 US disclosed